Burning Rock Biotech (BNR) Net Cash Flow: 2020-2025
Historic Net Cash Flow for Burning Rock Biotech (BNR) over the last 6 years, with Sep 2025 value amounting to $1.9 million.
- Burning Rock Biotech's Net Cash Flow rose 111.71% to $1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$8.4 million, marking a year-over-year increase of 72.37%. This contributed to the annual value of -$13.3 million for FY2024, which is 70.02% up from last year.
- As of Q3 2025, Burning Rock Biotech's Net Cash Flow stood at $1.9 million, which was up 120.43% from -$9.4 million recorded in Q2 2025.
- In the past 5 years, Burning Rock Biotech's Net Cash Flow ranged from a high of $26.1 million in Q1 2021 and a low of -$79.5 million during Q4 2022.
- Its 3-year average for Net Cash Flow is -$7.3 million, with a median of -$5.9 million in 2024.
- Its Net Cash Flow has fluctuated over the past 5 years, first tumbled by 225.21% in 2021, then skyrocketed by 196.85% in 2024.
- Over the past 5 years, Burning Rock Biotech's Net Cash Flow (MRQ) stood at -$29.2 million in 2021, then plummeted by 172.13% to -$79.5 million in 2022, then skyrocketed by 96.76% to -$2.6 million in 2023, then skyrocketed by 196.85% to $2.5 million in 2024, then dropped by 23.01% to $1.9 million in 2025.
- Its Net Cash Flow stands at $1.9 million for Q3 2025, versus -$9.4 million for Q2 2025 and -$3.5 million for Q1 2025.